D-1032-2020 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-1032-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Mar 13, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. The recall status is terminated (terminated Feb 9, 2021). Affected quantity: 624 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Mar 13, 2020
Termination Date
Feb 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
624 bottles

Product description

Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

Reason for recall

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Distribution pattern

Nationwide in the USA

Code information

Lot #: AA39490, Exp 03/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1032-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1032-2020. Report a data issue: hello@regdatalab.com.